AKT1 and neoplasm: For instance, Erianin can exert anti-tumor effects through the ERK pathway, ROS mediated JNK/c-Jun and AKT/mTOR pathways, PI3K/AKT/mTOR pathway, calcium/calmodulin dependent ferroptosis pathway [23–26].